(Auto)antibodies in inflammatory bowel diseases.

[1]  L. Arckens,et al.  Anti-alpha-enolase antibodies in patients with inflammatory Bowel disease. , 2008, Clinical chemistry.

[2]  P. Rutgeerts,et al.  Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease , 2007, Gut.

[3]  K. Van Steen,et al.  New serological markers in inflammatory bowel disease are associated with complicated disease behaviour , 2007, Gut.

[4]  S. Targan,et al.  NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives. , 2007, Gastroenterology.

[5]  Z. Halpern,et al.  Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. , 2006, Gastroenterology.

[6]  S. Targan,et al.  Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis , 2006, Gut.

[7]  Dennis Christie,et al.  Serum Immune Responses Predict Rapid Disease Progression among Children with Crohn's Disease: Immune Responses Predict Disease Progression , 2006, The American Journal of Gastroenterology.

[8]  R. Balicer,et al.  Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease , 2005, Gut.

[9]  S. Targan,et al.  Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. , 2005, Gastroenterology.

[10]  K. Van Steen,et al.  Pancreatic Autoantibodies in Inflammatory Bowel Disease , 2004, Inflammatory bowel diseases.

[11]  W. Mow,et al.  Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. , 2004, Gastroenterology.

[12]  P. Rutgeerts,et al.  The value of serologic markers in indeterminate colitis: a prospective follow-up study. , 2003, Gastroenterology.

[13]  Jonathan Braun,et al.  Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. , 2002, Gastroenterology.

[14]  S. Targan,et al.  Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. , 2001 .

[15]  P. Rutgeerts,et al.  Anti-Saccharomyces Cerevisiae Antibodies (ASCA), Phenotypes of IBD, and Intestinal Permeability: A Study in IBD Families , 2001, Inflammatory bowel diseases.

[16]  T. Sauerbruch,et al.  "Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines. , 2000, Gastroenterology.

[17]  S. Targan,et al.  Utility of perinuclear anti-neutrophil cytoplasmic antibodies (pANCA), anti-saccharomyces cerevisiae (ASCA), and anti-pancreatic antibodies (APA) as serologic markers in a population based cohort of patients with Crohn's disease (CD) and ulcerative colitis (UC) , 2000 .

[18]  S. Targan,et al.  Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease , 2000, Gut.

[19]  S. Targan,et al.  Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. , 1998, Gastroenterology.

[20]  O. Goulet,et al.  Anti-Saccharomyces cerevisiae mannan antibodies in familial crohn’s disease , 1998 .

[21]  S. Targan,et al.  Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role , 1998, Gut.

[22]  J. Satsangi,et al.  The Presence of Anti‐Neutrophil Antibodies Reflects Clinical and Genetic Heterogeneity Within Inflammatory Bowel Disease , 1998, Inflammatory bowel diseases.

[23]  G. Verbeke,et al.  Clustering of increased small intestinal permeability in families with Crohn's disease. , 1997, Gastroenterology.

[24]  S. Endres,et al.  Antinuclear Autoantibodies in Patients with Inflammatory Bowel Disease (High Prevalence in First-Degree Relatives) , 1997, Digestive Diseases and Sciences.

[25]  M. Scheurlen,et al.  Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens? , 1996, European journal of gastroenterology & hepatology.

[26]  S. Targan,et al.  Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. , 1996, Gastroenterology.

[27]  S. Targan,et al.  Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study. , 1996, Mayo Clinic proceedings.

[28]  P. Jacquinot,et al.  Specific antibody response to oligomannosidic epitopes in Crohn's disease , 1996, Clinical and diagnostic laboratory immunology.

[29]  E. Lindberg,et al.  P-ANCA in monozygotic twins with inflammatory bowel disease. , 1995, Gut.

[30]  S. Targan,et al.  High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. , 1995, Gastroenterology.

[31]  J. Lennard-jones,et al.  Antineutrophil antibodies in familial inflammatory bowel disease. , 1995, Gastroenterology.

[32]  S. Targan,et al.  Expression of a novel autoantibody defined by the VH3-15 gene in inflammatory bowel disease and Campylobacter jejuni enterocolitis. , 1994, Journal of immunology.

[33]  F. Seibold,et al.  Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. , 1994, Gastroenterology.

[34]  J. Colombel,et al.  Anti-neutrophil cytoplasmic autoantibodies in relatives of patients with ulcerative colitis. , 1992, Gastroenterology.

[35]  S. Targan,et al.  Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. , 1992, Gastroenterology.

[36]  F. Seibold,et al.  Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. , 1992, Gut.

[37]  F. Seibold,et al.  Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn's disease. , 1991, Gut.

[38]  J. Schölmerich,et al.  A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. , 1990, Immunobiology.

[39]  C. Fiocchi,et al.  High prevalence of antibodies to intestinal epithelial antigens in patients with inflammatory bowel disease and their relatives. , 1989, Annals of internal medicine.

[40]  M. Kerr,et al.  Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. , 1988, BMJ.

[41]  S. Korsmeyer,et al.  Lymphocytotoxic antibody in inflammatory bowel disease. A family study. , 1975, The New England journal of medicine.

[42]  W. Harrison.  AUTOANTIBODIES AGAINST INTESTINAL AND GASTRIC MUCOUS CELLS IN ULCERATIVE COLITIS , 1965 .

[43]  P. Perlmann,et al.  AUTOANTIBODIES IN HUMAN ULCERATIVE COLITIS , 1959, The Journal of experimental medicine.

[44]  R. Franchis,et al.  Long-term observation of the perinuclear anti-neutrophil cytoplasmic antibody status in ulcerative colitis patients. , 1998, Scandinavian journal of gastroenterology.

[45]  J. Gerrard,et al.  Letter: Sex-linked mental retardation. , 1974, Lancet.